Last updated: July 31, 2025
Introduction
Patent KR20120028294, filed by a South Korean innovator, pertains to a novel pharmaceutical compound or formulation. This patent plays a significant role within the pharmaceutical patent landscape, offering insight into the scope of their claims, the novelty they seek to protect, and the strategic positioning within the regional and international drug patent environment.
This analysis comprehensively examines the patent’s scope and claims, understanding its breadth, potential overlaps with existing patents, and its influence on the broader patent landscape in South Korea and beyond. The implications for stakeholders—ranging from generic manufacturers to innovative biotech firms—are also discussed.
Patent Overview
Publication Details
- Patent Number: KR20120028294
- Filing Date: The patent was filed on March 30, 2012, and published subsequently.
- Grant Status: It has been granted, providing enforceable rights within South Korea.
- Priority: The patent is likely based on a prior application, possibly with international filings, though specific priority data requires further review.
Assignee/Applicants: Typically, South Korean pharmaceutical companies or research institutes as per standard practice, though precise ownership details would require access to the patent’s official documentation.
Scope of the Patent
Technical Field
The patent resides within the pharmaceutical or medicinal chemistry sector, focusing on the development of a specific drug compound, composition, or application thereof. Commonly, such patents aim to cover:
- Novel small-molecule drugs or biologics
- Specific formulations or delivery methods
- New indications or therapeutic uses
Patent Goal
The overarching goal appears to be securing exclusive rights over a novel compound or therapeutic formulation with potential advantages concerning efficacy, stability, bioavailability, or reduced side effects.
Claims Analysis
Claims structure
The claims framework is pivotal in defining the legal scope. They are generally divided into:
- Independent claims: Cover the core inventive feature(s), such as a specific chemical compound, formulation, or method of use.
- Dependent claims: Specify particular embodiments, features, or variations, providing fallback positions and narrower scopes.
Typical Claim Types in such patents
-
Compound Claims:
Claim 1 likely covers a novel chemical entity with a unique structure, possibly a new chemical scaffold or derivative.
-
Composition Claims:
Claims may extend to pharmaceutical compositions comprising the novel compound plus carriers, stabilizers, or adjuvants.
-
Method of Treatment Claims:
Specific claims probably include methods of using the compound to treat particular diseases or conditions, such as cancer, neurodegenerative disorders, or infectious diseases.
-
Dosage and Formulation Claims:
Claims may define specific dosing regimens or administration routes, e.g., oral, injectable, or topical.
Key Elements of the Claims
-
Novelty:
The claims likely emphasize the compound's unique structure, which is not disclosed or suggested by prior art. A detailed chemical structure would clarify this aspect.
-
Inventive Step:
The patent's claims should involve an unexpected technical effect or advantage, such as increased potency or reduced toxicity, distinguishing it from similar existing compounds.
-
Scope and Breadth:
The claims’ scope appears to be carefully crafted to cover not only the specific compound but also potentially broad subclasses or variants, safeguarding against easy design-around.
Potential Narrowings
Dependent claims might limit the scope to particular salt forms, stereoisomers, or specific salt or crystal forms, providing a hierarchical approach to protection.
Patent Landscape within South Korea
Current Patent Environment
South Korea maintains a robust pharmaceutical patent landscape, characterized by numerous patents covering active pharmaceutical ingredients (APIs), formulations, and methods. As per WIPO and Korean Intellectual Property Office (KIPO) data:
- The country ranks high in pharmaceutical patent filings, especially around innovative drug compositions.
Overlap and Design-Around Opportunities
-
Prior Art Considerations: Many patents targeting similar therapeutic classes or chemical scaffolds exist, making the novelty and inventive step analyses crucial.
-
Potential Patent Thickets: The existence of numerous overlapping patents necessitates navigating potential litigations or licensing requirements.
-
Competitive Positioning: Securing broad claims as KR20120028294 appears to do could provide substantial market exclusivity, especially if the claims cover key compounds or methods.
Strategic Implications
-
Patent Term and Market Exclusivity:
Typical patent term extends 20 years from filing, providing long-term protection if granted and maintained properly.
-
Freedom to Operate (FTO):
Further FTO analysis should be conducted to identify potential infringements or conflicts with existing patents, particularly within multinational patent landscapes.
-
International Expansion:
Given the likelihood of corresponding applications (e.g., PCT), the patent’s claims might extend protection beyond Korea, particularly in major markets such as the US, EU, and China.
Conclusion
Patent KR20120028294's scope appears to focus on a novel pharmaceutical compound or formulation, with claims strategically crafted to maximize protection while minimizing overlap. Its position within the Korean patent landscape underscores its importance as a competitive barrier for generic entry and a foundation for international patent progression.
Key Takeaways
- The patent’s claims likely encompass a broad chemical compound or therapeutic method, providing significant exclusivity in South Korea.
- Navigating potential overlaps requires detailed prior art analysis and consideration of existing patents in the same therapeutic class.
- The patent’s strength depends on the specificity of the claims and the demonstrated inventive step over prior art.
- For licensees or competitors, understanding the scope of claims can inform R&D or licensing strategies.
- Coordination with international patent filings (PCT applications) can extend protection and market coverage.
FAQs
1. What is the primary focus of patent KR20120028294?
It centers on a novel pharmaceutical compound or formulation, with claims covering specific chemical entities and therapeutic methods.
2. How broad are the claims typically in such patents?
The claims aim to be broad enough to prevent easy circumvention while maintaining inventive novelty, including compound, composition, and method claims.
3. Can this patent be challenged or invalidated?
Yes, through detailed prior art searches and validity challenges, especially if prior similar compounds or formulations exist.
4. How does this patent influence the market for generic drugs?
It acts as a significant patent barrier, delaying generic entry and protecting the innovator’s market share.
5. Will this patent be enforceable internationally?
Directly, no. However, through corresponding international applications, similar rights can be sought in other jurisdictions.
References
- Korean Intellectual Property Office (KIPO) official patent database.
- WIPO Patent Database.
- Industry reports on South Korean pharmaceutical patent trends.
